{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:26:28Z","timestamp":1793107588380,"version":"4.5.0"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.7410","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T23:05:31Z","timestamp":1593212731000},"page":"e207410","source":"Crossref","is-referenced-by-count":139,"title":["Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm"],"prefix":"10.1001","volume":"3","author":[{"given":"Saketh R.","family":"Guntupalli","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine at Denver, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyse","family":"Brennecke","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine at Denver, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian","family":"Behbakht","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine at Denver, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tayebnejad","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine at Denver, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Breed","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine at Denver, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Marie","family":"Babayan","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine at Denver, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Cheng","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine at Denver, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin A.","family":"Ramzan","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine at Denver, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay J.","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine at Denver, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley R.","family":"Corr","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine at Denver, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Lefkowits","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine at Denver, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanelle","family":"Sheeder","sequence":"additional","affiliation":[{"name":"Division of Family Planning, Department of Obstetrics and Gynecology, University of Colorado School of Medicine at Denver, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Keck School of Medicine, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Flink","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado School of Medicine at Denver, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"zoi200320r2","first-page":"666","article-title":"The role of surgery in advanced epithelial ovarian cancer.","volume":"10","author":"Mart\u00edn-Came\u00e1n","year":"2016","journal-title":"Ecancermedicalscience"},{"issue":"34","key":"zoi200320r3","doi-asserted-by":"publisher","first-page":"8802","DOI":"10.1200\/JCO.2005.02.1287","article-title":"Does aggressive surgery only benefit patients with less advanced ovarian cancer? results from an international comparison within the SCOTROC-1 Trial.","volume":"23","author":"Crawford","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi200320r4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ygyno.2014.07.103","article-title":"Impact of obesity on surgical and oncologic outcomes in ovarian cancer.","volume":"135","author":"Kumar","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"9","key":"zoi200320r5","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1097\/IGC.0b013e3182a80aa7","article-title":"Incidence and predictors of venous thromboembolism after debulking surgery for epithelial ovarian cancer.","volume":"23","author":"Mokri","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"zoi200320r6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ejogrb.2013.06.004","article-title":"Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival.","volume":"170","author":"Abu Saadeh","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"zoi200320r7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/AOG.0b013e31823d389e","article-title":"Prevention of venous thromboembolic events after gynecologic surgery.","volume":"119","author":"Clarke-Pearson","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"12","key":"zoi200320r8","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.jacc.2016.12.039","article-title":"Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism.","volume":"69","author":"Konstantinides","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"zoi200320r9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.21873\/invivo","article-title":"Improvement of perioperative outcomes in major gynecological and gynecologic-oncological surgery with hemostatic gelatin-thrombin matrix.","volume":"31","author":"Watrowski","year":"2017","journal-title":"In Vivo"},{"issue":"34","key":"zoi200320r10","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.1200\/JCO.2007.14.1283","article-title":"American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.","volume":"25","author":"Lyman","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"zoi200320r11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update.","volume":"38","author":"Key","year":"2020","journal-title":"J Clin Oncol"},{"issue":"2","key":"zoi200320r12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report.","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"2","key":"zoi200320r13","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.1378\/chest.1412S3","article-title":"Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians evidence-based clinical practice guidelines.","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"issue":"2","key":"zoi200320r14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3928\/0147-7447-20050201-16","article-title":"Patient compliance with outpatient prophylaxis: an observational study.","volume":"28","author":"Colwell","year":"2005","journal-title":"Orthopedics"},{"issue":"6","key":"zoi200320r15","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1056\/NEJMoa0810773","article-title":"Apixaban or enoxaparin for thromboprophylaxis after knee replacement.","volume":"361","author":"Lassen","year":"2009","journal-title":"N Engl J Med"},{"issue":"9717","key":"zoi200320r16","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0140-6736(09)62125-5","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.","volume":"375","author":"Lassen","year":"2010","journal-title":"Lancet"},{"issue":"26","key":"zoi200320r17","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa1006885","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.","volume":"363","author":"Lassen","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"zoi200320r18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism.","volume":"369","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi200320r19","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for prevention of venous thromboembolism.","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi200320r21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/jth.2005.3.issue-4","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"1","key":"zoi200320r22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11239-006-5573-x","article-title":"Advances in the diagnosis of venous thromboembolism.","volume":"21","author":"Wells","year":"2006","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"zoi200320r23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1055\/s-0037-1613830","article-title":"Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer.","volume":"83","author":"Wells","year":"2000","journal-title":"Thromb Haemost"},{"issue":"26","key":"zoi200320r27","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa1006885","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.","volume":"363","author":"Lassen","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi200320r28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/IGC.0000000000000912","article-title":"Incidence of venous thromboembolism by type of gynecologic malignancy and surgical modality in the National Surgical Quality Improvement Program.","volume":"27","author":"Graul","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"zoi200320r29","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.thromres.2014.06.020","article-title":"Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.","volume":"134","author":"G\u00f3mez-Outes","year":"2014","journal-title":"Thromb Res"},{"key":"zoi200320r20","volume-title":"Scientific Tables","author":"Diem","year":"1962","edition":"6th ed"},{"key":"zoi200320r1","unstructured":"American Cancer Society. Cancer facts and figures 2014. Published 2014. Accessed June 1, 2020. https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2014.html"},{"key":"zoi200320r24","unstructured":"Optum. SF-8 health survey. Accessed June 1, 2020. https:\/\/www.optum.com\/solutions\/life-sciences\/answer-research\/patient-insights\/sf-health-surveys\/sf-8-health-survey.html"},{"key":"zoi200320r25","unstructured":"QualityMetric. Health outcomes scoring software 5.1, version 5.12017. Published 2016. Accessed June 1, 2020. https:\/\/www.amihealthy.com\/download\/installationguide_scoringsoftwarev5.pdf"},{"key":"zoi200320r26","unstructured":"Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events (CTCAE), version 4.02010. Updated March 27, 2020. Accessed June 1, 2020. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2767675\/guntupalli_2020_oi_200320.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T23:05:36Z","timestamp":1593212736000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2767675"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.7410","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]}}}